Credit Agricole’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Sell |
200,797
-17,266
| -8% | -$806K | 0.03% | 393 |
|
|
2025
Q4 | $6.43M | Buy |
218,063
+28,973
| +15% | +$787K | 0.02% | 529 |
|
|
2025
Q3 | $4.88M | Buy |
+189,090
| New | +$5.27M | 0.02% | 567 |
|
|
2025
Q1 | $9.21M | Sell |
324,710
-17,962
| -5% | -$637K | 0.03% | 402 |
|
|
2024
Q4 | $14.2M | Buy |
342,672
+159,589
| +87% | +$7.63M | 0.05% | 303 |
|
|
2024
Q3 | $12.2M | Buy |
183,083
+62,358
| +52% | +$5.73M | 0.06% | 248 |
|
|
2024
Q2 | $14.3M | Buy |
120,725
+48,084
| +66% | +$6.08M | 0.09% | 185 |
|
|
2024
Q1 | $7.41M | Sell |
72,641
-159,565
| -69% | -$16.1M | 0.13% | 206 |
|
|
2023
Q4 | $23.1M | Buy |
232,206
+39,103
| +20% | +$3.29M | 0.48% | 72 |
|
|
2023
Q3 | $19.9M | Buy |
193,103
+20,869
| +12% | +$2.33M | 0.61% | 64 |
|
|
2023
Q2 | $20.9M | Buy |
172,234
+54,113
| +46% | +$7.22M | 0.68% | 56 |
|
|
2023
Q1 | $18.1M | Buy |
118,121
+14,827
| +14% | +$2.45M | 0.77% | 45 |
|
|
2022
Q4 | $18.6M | Sell |
103,294
-4,634
| -4% | -$758K | 0.69% | 44 |
|
|
2022
Q3 | $12.8M | Sell |
107,928
-1,646
| -2% | -$250K | 0.43% | 61 |
|
|
2022
Q2 | $15.7M | Buy |
109,574
+14,755
| +16% | +$2.11M | 0.62% | 54 |
|
|
2022
Q1 | $16.3M | Buy |
94,819
+55,742
| +143% | +$9.38M | 0.51% | 62 |
|
|
2021
Q4 | $9.93M | Buy |
39,077
+21,196
| +119% | +$6.2M | 0.33% | 103 |
|
|
2021
Q3 | $6.88M | Buy |
17,881
+4,982
| +39% | +$1.84M | 0.25% | 120 |
|
|
2021
Q2 | $3.03M | Sell |
12,899
-6,591
| -34% | -$1.18M | 0.1% | 197 |
|
|
2021
Q1 | $2.55M | Buy |
19,490
+19,190
| +6,397% | +$2.78M | 0.1% | 182 |
|
|
2020
Q4 | $31K | Sell |
300
-4,500
| -94% | -$455K | ﹤0.01% | 430 |
|
|
2020
Q3 | $340K | Buy |
+4,800
| New | +$335K | 0.02% | 242 |
|
|
2020
Q2 | – | Sell |
-4,735
| Closed | -$142K | – | 496 |
|
|
2020
Q1 | $142K | Buy |
+4,735
| New | +$109K | 0.02% | 265 |
|
Other funds holding MRNA
VCM
VPM
